All In Biotech

Drug Trial Radar · NCT01845194

Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics

Open Label Repeated Dose Study for the Evaluation of Heritability of and Genetic Influences on Drug Pharmacokinetics (TWINS II)

Last checked: Nov 20, 2026Latest source record: Apr 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

117

Actual

Start

Dec 2009

Primary completion

Oct 2013

Study completion Oct 2013

Sponsor

Sponsor type
Academic, hospital or other
First posted
May 3, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This human pharmacokinetic study investigates, whether processes of drug metabolism and transport are determined by genetic or hereditary factors. Therefore, approved drugs are applied to twins and metabolism and transport processes are investigated.

Conditions

  • Drug Biotransformation
  • Membrane Transport

Interventions

  • CodeineDrug

    Treatment period 2: 5 mg Codeine once

  • MidazolamDrug

    Treatment period 1: 0.2 mg Midazolam 3x Treatment period 2: 1 mg Midazolam once

  • PravastatinDrug

    Treatment period 2: 5 mg Pravastatin once

  • TorsemideDrug

    Treatment period 1: 2.5 mg Torsemide 3x Treatment period 2: 0.25 mg Torsemide once

  • TalinololDrug

    Treatment period 1: 50 mg Talinolol 3x Treatment period 2: 2.5 mg Talinolol once

  • CaffeineDrug

    Treatment period 1: 50 mg Caffeine 3x

  • MetoprololDrug

    Treatment period 1: 5 mg Metoprolol 3x

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. plasma drug concentrationsTime frame: up to 24 h after drug application

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dept. of Clinical Pharmacology, Georg-August-University of Goettingen

    Göttingen, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.